| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/19/2006 | US20060014752 Heterocyclic anti-epileptogenic agents and methods of use thereof |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
| 01/18/2006 | EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | CN1723200A (2-carboxamido) (3-amino) thiophene compounds |
| 01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237053C Process for producing quinoline carboxyaldehyde derivative and intermediate thereof |
| 01/17/2006 | US6987187 Process for preparation of amidine derivatives |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/12/2006 | WO2006004561A1 Process for the preparation of gatifloxacin and regeneration of degradation products |
| 01/12/2006 | WO2006003395A2 Molten salts, method of their production and process for generating hydrogen peroxide |
| 01/12/2006 | WO2005100320A3 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them |
| 01/12/2006 | WO2005094810A3 Novel pharmaceutical compositions |
| 01/12/2006 | WO2005066115A3 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009488 Prodrugs of selective androgen receptor modulators and methods of use thereof |
| 01/12/2006 | US20060009487 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | CA2571546A1 Molten salts, method of their production and process for generating hydrogen peroxide |
| 01/11/2006 | EP1614682A1 Process for producing quinoline compound |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613599A1 A process for the preparation of 5-(haloacetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones |
| 01/11/2006 | EP1613598A2 Methods of preparing aripiprazole crystalline forms |
| 01/11/2006 | EP1613592A2 Hydroxamic acid compounds and methods of use thereof |
| 01/11/2006 | EP1613322A2 Aminoquinoline compounds |
| 01/11/2006 | EP1613319A2 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/11/2006 | EP1613315A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1322583B1 Method for the isomerisation of allyl alcohols |
| 01/11/2006 | CN1720230A Process for producing quinolinecarbaldehyde |
| 01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/11/2006 | CN1235881C Improved method for preparing fluoro-quinolone carboxylic acid |
| 01/11/2006 | CN1235880C Quinolinenone kind derivative and its accetable salt, its preparation method, application in preparation of alipyrazole and preparation of alipyrazole |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/05/2006 | WO2006002421A2 Modulators of atp-binding cassette transporters |
| 01/05/2006 | WO2006001846A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| 01/05/2006 | WO2006000288A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | US20060004204 Process for preparation of montelukast and its salts |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004043 Indazole compounds and methods of use thereof |
| 01/05/2006 | US20060004040 Method for the prevention and/or treatment of atherosclerosis |
| 01/05/2006 | US20060004001 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders |
| 01/05/2006 | US20060003089 Electroluminescent quinolates |
| 01/05/2006 | US20060003011 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2589565A1 Amido compounds and their use as pharmaceuticals |
| 01/05/2006 | CA2572153A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2559824A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril |
| 01/04/2006 | EP1611103A1 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610790A2 Anticancer compounds |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | CN1717411A Phosphorescence compound and electro field light emitting device having the same |
| 01/04/2006 | CN1717175A Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 01/04/2006 | CN1234691C Process for producing quinoline-3-carboxylic acid compound |
| 01/03/2006 | US6982334 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid |
| 01/03/2006 | US6982332 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 12/29/2005 | WO2005123746A1 Methods for preparation of levofloxacin and ofloxacin |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123686A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/29/2005 | WO2005123685A1 Tetrahydroquinolones and aza-analogues thereof for use as dpp-iv inhibitors in the treatement of diabetes |
| 12/29/2005 | WO2005123684A2 Enantioselektive preparation of quinoline derivative |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288331 Compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 12/29/2005 | US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 12/29/2005 | US20050288302 Novel crystalline forms of gatifloxacin |
| 12/29/2005 | US20050288301 Novel crystalline forms of gatifloxacin |
| 12/29/2005 | US20050288284 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | CA2568394A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 12/29/2005 | CA2566388A1 Enantioselective preparation of quinoline derivative |
| 12/28/2005 | EP1610126A1 A system for determining the electrical potential across a membrane |
| 12/28/2005 | EP1608643A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/27/2005 | US6979740 Process for preparation of ring-substituted 8-aminoquinoline analogs as antimalarial agents |
| 12/27/2005 | US6979739 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |